Pharmabiz13h
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale: Shardul Nautiyal, Mumbai ...
Pharmabiz5h
BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia
BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia: Stockholm, Sweden Friday, November 29, 2024, 16:00 Hrs [IST] BioArctic ABs ...
Pharmabiz6h
Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List
Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List: San Francisco, US Friday, November 29, 202 ...
Pharmabiz6h
CureSMA Foundation of India lauds government and judiciary for historic Rs. 900+ crore allocation to rare disease treatment
CureSMA Foundation of India lauds government and judiciary for historic Rs. 900+ crore allocation to rare disease treatment: Our Bureau, Mumbai Friday, November 29, 2024, 14:30 Hr ...
Pharmabiz7h
CDSCO declares 60 drug samples tested in October as NSQ, three as spurious
CDSCO declares 60 drug samples tested in October as NSQ, three as spurious: Our Bureau, New Delhi Friday, November 29, 2024, 13:30 Hrs [IST] The Central Drugs Standard Control Org ...
Pharmabiz7h
BIO INX and Carl Roth partner to expand access to 3D bioprinting solutions
BIO INX and Carl Roth partner to expand access to 3D bioprinting solutions: Ghent, Belgium Friday, November 29, 2024, 14:00 Hrs [IST] BIO INX, a leader in advanced bioinks for 3D ...
Pharmabiz7h
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg
The Department of Pharmaceuticals (DoP) has upheld the drug price regulator's action of fixing ceiling price of antiviral drug acyclovir 800 mg per tablet, rejecting a review application filed by ...
Pharmabiz11h
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab: Hong Kong Friday, November 29, 2024, 10:00 Hrs [IST] Akeso, Inc., a leading biopharmace ...
Pharmabiz8h
UK MHRA approves new diagnostic agent, flortaucipir for adult patients showing signs of cognitive impairment for Alzheimer’s disease
UK MHRA approves new diagnostic agent, flortaucipir for adult patients showing signs of cognitive impairment for Alzheimer’s disease: United Kingdom Friday, November 29, 2024, 1 ...
Pharmabiz9h
Lin BioScience’s LBS-007 gets US FDA Fast Track Designation to treat acute myeloid leukaemia and acute lymphocytic leukaemia
Lin BioScience’s LBS-007 gets US FDA Fast Track Designation to treat acute myeloid leukaemia and acute lymphocytic leukaemia: Taipei City, Taiwan Friday, November 29, 2024, 12:0 ...
Pharmabiz9h
Pfizer India and the State of Goa launch ‘Project Parivartan’ to tackle AMR and strengthen infection control
Pfizer India and the State of Goa launch ‘Project Parivartan’ to tackle AMR and strengthen infection control: Our Bureau, Bengaluru Friday, November 29, 2024, 12:15 Hrs [IST] ...
Pharmabiz10h
Lupin receives US FDA tentative approval for generic Janumet tablets
Lupin receives US FDA tentative approval for generic Janumet tablets: Our Bureau, Mumbai Friday, November 29, 2024, 11:15 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...